Table: begin end state 1 22 signal peptide 23 34 non-cytoplasmic 35 54 transmembrane 55 83 cytoplasmic 84 105 transmembrane 106 121 non-cytoplasmic 122 141 transmembrane 142 147 cytoplasmic 148 173 transmembrane 174 192 non-cytoplasmic 193 212 transmembrane 213 229 cytoplasmic 230 252 transmembrane 253 277 non-cytoplasmic 278 307 transmembrane 308 327 cytoplasmic 328 347 transmembrane 348 353 non-cytoplasmic 354 376 transmembrane 377 393 cytoplasmic 394 411 transmembrane 412 415 non-cytoplasmic 416 434 transmembrane 435 445 cytoplasmic 446 470 transmembrane 471 473 non-cytoplasmic
Input: >SMa1668 FitnessBrowser__Smeli:SMa1668 MAQKLSLFALTGMVVGSMVGAGIFSLPRTFGVATGPFGAIIAWCIAGGGMYMLARVFQSL AERKPDLDAGVFAYAKEGFGDYPGFLSAFGYWIGSCIGNVSYWVLIKSTLGNFFPVFGDG NTVVAILFASVGIWLFHFMILRGIQQAAFVNTVVTVAKVIPIIAFIIILFFFFKLDLFRL NFWGGEGMPEATLLQQIQATMLATVFVFIGIEGASNYSRYAQARSDIGTATIMGFIGVSA LMVLVTLLPYAALTRPEIAAMSQPSMAGVLAAVVGPWGAVFISIGVIVSVLGAYLAWSLV CAEVLYVAARTDDMPRLFGTENQNKVPAAALWLTNIVVQLFVISTYWSQDAFALMLNLTS SMSLIPYMFVAAFGFMLAQRAETYEVRPRERTRDLIIASIAAVYTFFMIVAGGIKFVLLS ALLYAPGTILYFWARRERGKRVFNTSIDWLIFATAVIGCFAAIIGLSTGYLTI
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server